Taking the next leap in
antibody medicines for cancer
Koblano Therapeutics develops differentiated, next-generation antibody products for patients with cancer.
Our team
Koblano was founded by a team with long experience in building, growing and leading international biotechnology companies, from drug development to partnering and commercialization.
Partnering
We welcome conversations with pharmaceutical and biotechnology companies, academic institutions and investors who share our ambition.